Chronic Risk
Screenings &
Assessments
Screen. Test. Treat.
TriageIQ™ | Multi-Domain Pre-Screeners
Chronic Risk
Screenings &
Assessments
Screen. Test. Treat.
One Room. Complete Insight. DTC helps existing clinics build one-room turnkey chronic risk detection programs that identify hidden risk signals earlier.
Diabetes Testing Centers™ (DTC) has evolved beyond diabetes-related risk detection into a broader chronic-risk platform for modern primary care. Designed to integrate inside existing PCP clinics using as little as one dedicated room, DTC allows practices to add structured pre-screening and focused assessment pathways without building a separate clinic, disrupting daily operations, or requiring major space expansion.
DTC was built for primary care organizations and helps providers detect hidden risk signals earlier, support medical-necessity documentation, and guide patients toward timely care before silent risks become serious complications.
DTC was founded by former family practice owners who saw firsthand how often chronic risks are missed and patients had already begun suffering from preventable damage. That experience, combined with enterprise healthcare leadership in diagnostics and diabetes, shaped DTC’s development of scalable, non-invasive, billable point-of-care programs. Today, with access to a national network of more than 20,000 independent practices, DTC helps providers use TriageIQ™ as the intake-level pre-screener, then determine which focused screeners, assessments, or non-invasive diagnostics may be appropriate during the same visit.
Most chronic diseases do not begin with a diagnosis. They often begin years earlier with subtle changes in how a patient feels, functions, or moves — changes that may not appear in labs and may never become documented concerns. Patients often notice these changes but explain them away as aging, stress, fatigue, or “just getting older.” They may not schedule a visit, mention them during an existing one, or follow up until the symptoms become impossible to ignore. By then, the underlying disease process may have been active for years.
This is the gap structured chronic-risk detection is designed to close — not by adding complexity, but by surfacing what patients may already be experiencing while they’re already present in the care setting. No extra appointment. No separate referral. No waiting for the patient to decide a symptom is worth reporting. By building detection into the front end of care, organizations can capture risk in the room, document medical necessity when it’s present, and create a pathway forward before the window for early intervention closes. The visit doesn’t change, only the clinical intelligence it finds does.
Find Hidden Risk Signals
The earliest risk signals emerge in a patient through symptoms, functional change, and subtle clinical patterns that precede what is formally documented in the chart. Adults represent the largest share of the U.S. population and carry the greatest overall burden of chronic disease risk. Adults represent the largest immediately addressable clinical population
This matters because most chronic conditions become more common, measurable, and clinically actionable during adulthood. TriageIQ™ helps pre-screen adult patients for early risk signals across five core clinical domains, giving providers a broader intake picture before deciding whether focused single-domain screeners, assessments, or testing may be needed.
🔎 Population Health: A broad baseline view of patient risk and care-navigation needs.
❤️ Cardiometabolic: Related to metabolic, vascular, and cardiovascular risk direction.
🧠 Neurological: Supports early recognition of brain, nerve, balance, and functional-risk patterns.
🧩 Behavioral: Helps surface behavioral, emotional, sleep, and whole-person risk signals.
⚡ Pain & Function: Related to pain burden, movement, daily activity, and physical function.
TriageIQ™ is a proprietary 3-minute adult multi-domain pre-screener that helps identify potential risk signals across five clinical domains and supports provider review for medically necessary follow-up.
Detecting these risks earlier helps protect patients before complications become life-altering. DTC delivers the clinical strategy behind Chronic Risk Assessments used by providers nationwide, with flexible onboarding, workflow integration, and a scalable model designed to support earlier identification, better documentation, and recurring clinical value.
Turn Intake to Insight
The clinical case for earlier testing is not theoretical—it is measurable and documentable. Chronic conditions including diabetes, hypertension, peripheral neuropathy, cognitive decline, and cardiovascular disease often follow a predictable trajectory: a long silent phase where damage can accumulate before symptoms become obvious, followed by a later clinical threshold where intervention becomes more reactive, costly, and complex.
Most primary care workflows are not built to capture risk during that earlier window. Patients present with a chief complaint. Providers respond to what is reported. But what is not reported—early neuropathic changes, subtle cognitive shifts, vascular risk signals, behavioral health burden, or functional decline—may be missed when intake is not structured to pre-screen across multiple domains.
DTC exists to change that equation. Through in-clinic, remote, and mobile testing options, DTC helps practices identify risk earlier from wherever the patient is located—inside the clinic, at home, in the workplace, or through mobile outreach. The programs, diagnostics, and workflows DTC brings into a practice are designed to test earlier, within the visits and patient relationships that already exist, for the conditions that create the greatest long-term harm when missed.
The providers who benefit most aren’t adding complexity. They’re unlocking clinical value already present in their existing patient panel and visit flow by using a more structured pathway to surface risk earlier, document medical necessity, and guide appropriate next steps.
Earlier Detection
National Guidelines
National guidelines are clear. What is less clear in most busy practices is how to meet them consistently within existing visit structures without adding staff, extending appointment times, or relying entirely on provider recall. Until now.
Many guidelines and quality measures are organized around a single condition, a single risk category, or a single clinical domain. But real-world care does not happen one domain at a time. In primary care and specialty clinics, patients often arrive with overlapping risks, incomplete complaints, and silent conditions that may not be obvious during a short visit.
That is where TriageIQ™ creates value. As a multi-domain pre-screener, TriageIQ™ helps identify potential risk signals across multiple clinical domains at intake. Those signals can help the provider determine whether a focused single-domain screener, assessment, diagnostic test, or care pathway may be clinically appropriate. Instead of relying entirely on time, memory, or chance, TriageIQ™ gives practices a structured front-end process to identify potential concerns earlier and organize them for provider review.
Important clinical significance: Diabetic peripheral neuropathy (DPN) deserves specific attention because it may be one of the earliest measurable warning signs of broader metabolic, vascular, neurologic, and functional decline.
Small fiber risk signals may reflect early metabolic dysfunction, impaired glucose tolerance, autonomic involvement, or inflammatory/vascular stress before symptoms are clearly reported.
Large fiber involvement may indicate loss of protective sensation, increasing concern for balance impairment, falls, foot ulcers, wounds, infection, and amputation risk.
DPN is not only a foot-health concern, it may be one of the earliest visible risk signals of broader metabolic, vascular, neurologic, functional, or retinal risk—helping providers determine whether additional focused pathways may be clinically appropriate.
Neuropathy Signals More
Start by improving intake with multi-domain pre-screening. From there, patient-reported signals help reveal where focused screeners, assessments, testing pathways, or referral opportunities may already exist inside your practice.
Getting Started Is Simple:
Start with TriageIQ™ at Intake
Use TriageIQ™ as the front-door multi-domain pre-screener to identify potential risk signals quickly and consistently at the beginning of care.
Review the Risk Signals in Your Patient Population
As results are collected, your clinic can see which risk domains appear most often and where focused screeners, in-house assessments, testing, or referrals may be most appropriate.
Prioritize the Highest-Impact Pathways First.
TriageIQ™ creates value at intake immediately. Some patients may warrant next-step review right away, while broader clinic patterns typically become clearer within the first 30 to 90 days of consistent use.
Schedule a Meeting to Build Your Rollout Plan. We’ll help determine the best starting point, review program options, and provide a financial pro forma based on your location, workflow, and payor mix so implementation begins with a clear path to deployment.
Start Here
"Book a 15‑minute walkthrough” to see how easily DTC programs integrate into your existing workflows.